BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15692902)

  • 1. [Multiple myeloma -- diagnostics].
    Schroers R; Zettl F; Jung W
    Dtsch Med Wochenschr; 2005 Feb; 130(6):278-82; quiz 287-90. PubMed ID: 15692902
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of bone marrow plasma cell kinetics in the differential diagnosis of monoclonal gammopathies].
    Pini E; Tassinari D; Gianni L; Fattori P; Sartori S; Pasquini E; Ravaioli A
    Recenti Prog Med; 1995 Jun; 86(6):242. PubMed ID: 7624585
    [No Abstract]   [Full Text] [Related]  

  • 3. Defining IgM multiple myeloma.
    Owen RG; Feyler S; O'Connor SJ; Bond LR; de Tute RM; Rawstron AC
    Am J Hematol; 2011 Aug; 86(8):717; author reply 718-9. PubMed ID: 21761439
    [No Abstract]   [Full Text] [Related]  

  • 4. [Laboratory diagnosis of myeloma disease (review of the literature)].
    Lugovskaia SA
    Vrach Delo; 1982 Jan; (1):57-61. PubMed ID: 7041423
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis versus differential diagnosis of multiple myeloma].
    Bessmel'tsev SS
    Vopr Onkol; 2004; 50(4):406-16. PubMed ID: 15605762
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the usefulness of bone marrow sections and smears in diagnosis of multiple myeloma.
    Buss DH; Prichard RW; Hartz JW; Cooper MR
    Hematol Pathol; 1987; 1(1):35-43. PubMed ID: 3504429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow trephine biopsy findings in myeloma with small-lymphoid cells and CCND1 translocation.
    Abdalla S; May PC; Garimberti E; Naresh KN
    Am J Hematol; 2011 Dec; 86(12):1038. PubMed ID: 21898528
    [No Abstract]   [Full Text] [Related]  

  • 8. [Silent onset of multiple myeloma. How to diagnosis and when to treat?].
    Bartl R
    Internist (Berl); 1986 Mar; 27(3):192-200. PubMed ID: 3086250
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple myeloma: how far have we come?
    Anderson KC
    Mayo Clin Proc; 2003 Jan; 78(1):15-7. PubMed ID: 12528872
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidemiology, diagnosis and clinical aspects of multiple myeloma].
    Storch H; Gunold H; Mehnert WH; Bernstein P
    Z Arztl Fortbild (Jena); 1989; 83(24):1221-6. PubMed ID: 2629349
    [No Abstract]   [Full Text] [Related]  

  • 11. Conventional diagnostics in multiple myeloma.
    San Miguel JF; Gutiérrez NC; Mateo G; Orfao A
    Eur J Cancer; 2006 Jul; 42(11):1510-9. PubMed ID: 16762540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the usefulness of various cytoenzymatic studies in the differential diagnosis of multiple myeloma and plasmacytic reaction of bone marrow].
    Mariańska B; Maj S; Apel D; Płachecka M
    Acta Haematol Pol; 1985; 16(3-4):117-21. PubMed ID: 3835767
    [No Abstract]   [Full Text] [Related]  

  • 13. [Smoldering indolent multiple myeloma].
    Andreeva NE
    Ter Arkh; 1983; 55(8):55-9. PubMed ID: 6635957
    [No Abstract]   [Full Text] [Related]  

  • 14. IgM multiple myeloma: more on a rare and heterogeneous disease.
    Cabrera Q; Chantepie S; Salaun V; Levaltier X; Troussard X; Macro M
    Am J Hematol; 2011 Aug; 86(8):717-8; author reply 718-9. PubMed ID: 21630314
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum beta 2 microglobulin in multiple myeloma and related plasma cell dyscrasias.
    Pasquini E; Tiraferri E; Fattori PP; Fabbri I; Gobbi M
    Haematologica; 1987; 72(1):17-21. PubMed ID: 3108090
    [No Abstract]   [Full Text] [Related]  

  • 16. IgG4-related disease with bone marrow involvement mimicking multiple myeloma.
    Tang SH; Lin MH; Du JS; Liu YC; Hsiao HH; Liu TC
    Br J Haematol; 2017 Jun; 177(5):673. PubMed ID: 28439907
    [No Abstract]   [Full Text] [Related]  

  • 17. [Multiple bone myelomas].
    Roussel M; Gastinne T; Leleu X
    Rev Prat; 2009 Oct; 59(8):1143-52. PubMed ID: 19894462
    [No Abstract]   [Full Text] [Related]  

  • 18. The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells.
    Ng AP; Wei A; Bhurani D; Chapple P; Feleppa F; Juneja S
    Haematologica; 2006 Jul; 91(7):972-5. PubMed ID: 16818287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculation.
    Hillengass J; Zechmann C; Bäuerle T; Wagner-Gund B; Heiss C; Benner A; Ho A; Neben K; Hose D; Kauczor HU; Goldschmidt H; Delorme S; Moehler T
    Clin Cancer Res; 2009 May; 15(9):3118-25. PubMed ID: 19366830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kahler's disease?].
    Holdrinet RS
    Ned Tijdschr Geneeskd; 1987 Nov; 131(45):2001-3. PubMed ID: 3683621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.